Evidence map›Paper›PMID 23824211›Full record

ArticlePloS one2013

Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates.

Michelle C Swick, Michael A Evangelista, Truston J Bodine, Jeremy R Easton-Marks, Patrick Barth, Minita J Shah, Christina A Bormann Chung, Sarah Stanley, Stephen F McLaughlin, Clarence C Lee and 7 more

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michelle C SwickInterdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America ; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America.
Michael A Evangelista
Truston J Bodine
Jeremy R Easton-Marks
Patrick Barth
Minita J Shah
Christina A Bormann Chung
Sarah Stanley
Stephen F McLaughlin
Clarence C Lee
Vrunda Sheth
Quynh Doan
Richard J Hamill
David Steffen
Lauren B Becnel
Richard Sucgang
Lynn Zechiedrich

Funding

COMBATTING QUINOLONE ANTIMICROBIAL RESISTANCER01AI054830 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ZECHIEDRICH, LYNN · 2004 to 2012
$3.2M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
Training in Pharmacoinformatics(RMI)T90DK070109 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI STANCEL, GEORGE M. · 2004 to 2008
$1.6M
NIAID NIH HHS R01 AI054830NIDDK NIH HHS T90 DK070109NIGMS NIH HHS T32 GM088129
6 · The paper itself

Abstract

Current efforts to understand antibiotic resistance on the whole genome scale tend to focus on known genes even as high throughput sequencing strategies uncover novel mechanisms. To identify genomic variations associated with antibiotic resistance, we employed a modified genome-wide association study; we sequenced genomic DNA from pools of E. coli clinical isolates with similar antibiotic resistance phenotypes using SOLiD technology to uncover single nucleotide polymorphisms (SNPs) unanimously conserved in each pool. The multidrug-resistant pools were genotypically similar to SMS-3-5, a previously sequenced multidrug-resistant isolate from a polluted environment. The similarity was evenly spread across the entire genome and not limited to plasmid or pathogenicity island loci. Among the pools of clinical isolates, genomic variation was concentrated adjacent to previously reported inversion and duplication differences between the SMS-3-5 isolate and the drug-susceptible laboratory strain, DH10B. SNPs that result in non-synonymous changes in gyrA (encoding the well-known S83L allele associated with fluoroquinolone resistance), mutM, ligB, and recG were unanimously conserved in every fluoroquinolone-resistant pool. Alleles of the latter three genes are tightly linked among most sequenced E. coli genomes, and had not been implicated in antibiotic resistance previously. The changes in these genes map to amino acid positions in alpha helices that are involved in DNA binding. Plasmid-encoded complementation of null strains with either allelic variant of mutM or ligB resulted in variable responses to ultraviolet light or hydrogen peroxide treatment as markers of induced DNA damage, indicating their importance in DNA metabolism and revealing a potential mechanism for fluoroquinolone resistance. Our approach uncovered evidence that additional DNA binding enzymes may contribute to fluoroquinolone resistance and further implicate environmental bacteria as a reservoir for antibiotic resistance.

Indexed as

GenotypeAnti-Bacterial AgentsDNA, BacterialDrug Resistance, BacterialEscherichia coliFluoroquinolonesMicrobial Sensitivity TestsPolymorphism, Single NucleotideAnti-Bacterial AgentsDNA, BacterialFluoroquinolones

Identifiers

PMID23824211
PMCPMC3688849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.